Drug Ring for Glaucoma or High Eye Pressure
Part of Eyes & vision clinical trials.
This study tests a new medication ring that sits in your eye to treat glaucoma or high eye pressure. The ring slowly releases medicine over time and may help lower pressure in your eye more safely and conveniently than daily eye drops.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have mild to moderate open-angle glaucoma or ocular hypertension (high pressure in the eye)
- You have had your cataract removed (pseudophakic) or plan to have it removed
- You do not have uncontrolled diabetes, high blood pressure, or other serious health conditions
- You have not had eye surgery to correct vision or treat glaucoma
- You do not have other eye diseases or conditions besides open-angle glaucoma or ocular hypertension
- If you can become pregnant, you agree to use birth control during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new implant that releases medicine for glaucoma while you have cataract surgery. It may help lower eye pressure without using daily drops.
This study tests a new eye drop medicine (DNN.31.19.026) to lower pressure inside the eye for people with glaucoma or ocular hypertension. The goal is to see if it works safely when combined with other eye pressure medications.
This trial tests if a bimatoprost implant placed during cataract surgery (combined with a special lens) can lower eye pressure better than standard timolol eye drops. It may help people with mild to moderate glaucoma or high eye pressure who are already planning cataract surgery.
This study looks at how certain glaucoma eye drops affect the surface of your eye. It tests a new implant that may reduce damage and improve comfort.
This trial tests a tiny implant called Preserflo to treat glaucoma (high eye pressure) that hasn't been controlled with eyedrops. The surgery aims to lower pressure safely while avoiding complications like pressure that drops too low.
This Phase 3 study compares two versions of the same glaucoma eye-drop medicine (bimatoprost 0.01%) to see how similarly they work and their effect on eye pressure. It may help people with chronic open-angle glaucoma or ocular hypertension who need treatment in both eyes.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.